Procalcitonin as a Diagnostic Tool in Immunocompromised Patients
Author Information
Author(s): Bele Nicolas, Darmon Michael, Coquet Isaline, Feugeas Jean-Paul, Legriel Stéphane, Adaoui Nadir, Schlemmer Benoît, Azoulay Élie
Primary Institution: AP-HP, Hôpital Saint-Louis, Medical ICU Department, Paris, France
Hypothesis
The study aimed to assess the diagnostic accuracy of procalcitonin (PCT) in critically ill immunocompromised patients.
Conclusion
PCT concentrations may help to rule out bacterial infection in critically ill immunocompromised patients, despite limited specificity.
Supporting Evidence
- PCT concentrations on day 1 had 100% sensitivity but only 63% specificity for diagnosing bacterial sepsis.
- The area under the ROC curve was 0.851, indicating good diagnostic performance.
- PCT levels were significantly higher in patients with bacterial infections compared to those without.
Takeaway
Doctors can use a blood test called procalcitonin to help figure out if sick patients with weak immune systems have a bacterial infection, but it's not perfect.
Methodology
This was a prospective, observational study that included patients with suspected sepsis and classified them into diagnostic groups.
Potential Biases
The study may have been biased due to the prior administration of antibiotics before ICU admission.
Limitations
The population was heterogeneous, and the timing of PCT measurement may have limited the assessment of bacterial infection risk.
Participant Demographics
Median age was 54 years; 53.8% had hematological disorders, 26% had HIV, and 21.8% had solid cancers.
Statistical Information
P-Value
0.0006
Confidence Interval
95% CI 0.782-0.919
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website